Secondly, the SWELL1-LRRC8 complex is widely expressed in various tissues and cell types, including pancreatic beta cells, metabolic tissues, and cancer cells (Qiu et al., 2014), which poses a dual challenge of target specificity and safety for drug development. This evidence concerns the gene LRRC8A and cancer.